Rayliant Quantamental China Equity ETF (RAYC)
- Previous Close
13.69 - Open
13.70 - Bid --
- Ask 13.76 x 1100
- Day's Range
13.70 - 13.75 - 52 Week Range
11.88 - 16.85 - Volume
5,792 - Avg. Volume
13,132 - Net Assets 36.42M
- NAV 13.75
- PE Ratio (TTM) 9.94
- Yield 4.34%
- YTD Daily Total Return 6.91%
- Beta (5Y Monthly) 0.59
- Expense Ratio (net) 0.80%
The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in equity securities of issuers based in China. The equity securities in which it primarily invests are common stock, preferred stock, ADRs, and REITs. The fund may invest in securities of companies with any market capitalization. It may also invest in ETFs to equitize cash, and engage in securities lending. From time to time, the fund may focus its investments in a particular sector, such as the financials or consumer discretionary sector. It is non-diversified.
Rayliant
Fund Family
China Region
Fund Category
36.42M
Net Assets
2020-12-30
Inception Date
Performance Overview: RAYC
Trailing returns as of 4/24/2024. Category is China Region.
People Also Watch
Holdings: RAYC
Top 10 Holdings (29.60% of Total Assets)
Sector Weightings
Recent News: RAYC
Research Reports: RAYC
Daily – Vickers Top Buyers & Sellers for 04/25/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
CHRS: What does Argus have to say about CHRS?
COHERUS BIOSCIENCES INC has an Investment Rating of SELL; a target price of $4.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetCHRS: What does Argus have to say about CHRS?
COHERUS BIOSCIENCES INC has an Investment Rating of SELL; a target price of $6.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
RatingPrice TargetPLCE: Raising target price to $31.00
CHILDREN'S PLACE INC/THE has an Investment Rating of HOLD; a target price of $31.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice Target